How Unifying Data and Connecting Systems Drives Business Success in Pharma

Pharmaceutical companies are facing increased pressure to do more with less. This is pushing many of them to look to digital solutions to help unlock operational efficiencies, streamline processes, and reduce costs. These solutions help pharma companies achieve business success while still keeping the patient top of mind. In fact, unifying data and connecting systems improves the patient experience. It makes it possible for pharmaceutical companies to grant easier access to their products, promote therapy adherence, and foster collaboration across care teams. The end result? Improved overall health outcomes and a more efficient business operation.

Read this guide to learn how an integrated healthcare and life sciences platform can deliver value for your organization.

Chapter 1: Unify data to uncover efficiencies, reduce costs, and drive engagement

Patients should be the focus of every pharmaceutical organization. A patient-centric approach combined with comprehensive, coordinated care is the key to better patient outcomes. This requires that companies find a way to tailor patient journeys and foster cross-team collaboration without sacrificing business success. Cloud-based technology can help. With the right tools, pharma companies can deliver personalized care both efficiently and effectively.

An integrated life sciences platform is one such tool. It breaks down silos by unifying data across all parties, making it easy for everyone to communicate quickly and efficiently. It brings pharma companies closer to providers and patients, which spurs increased awareness about available therapies and promotes adherence through ongoing education and support programs. This is incredibly valuable considering adherence is still a half-trillion dollar problem in the US.

Uniting data in one central location also helps companies better understand patients. Because information is captured and documented across care teams, it’s easy to tap into things like a patient’s preferred communication channel and/or potential barriers to care. This allows pharma companies to be personal, proactive, and precise in their communications and marketing efforts. Remaining close to patients throughout their health journey also has the potential to provide insight into how treatments and medications work in the real world. Organizations can then use this valuable real-world data for R&D purposes to continually refine treatment regimens.

Ultimately, modernizing systems gives pharmaceutical companies a 360-degree view into the entirety of a patient’s journey in real time. It captures all pertinent information up front, which minimizes errors and ensures there are no surprises. This helps pharma companies better understand patients, solve any treatment issues, and spot problem areas before they have the potential to translate into lost time and money.

Chapter 2: Drive better collaboration across care teams

Pharmaceutical companies play a key role in helping patients achieve the best possible outcomes. They have a lot to offer both patients and providers in the way of drug therapies, promising clinical trials, or emerging gene therapy treatments. But in many cases, neither patients nor providers even know these opportunities exist. This is evidenced by the fact that despite a high degree of interest (>71%), only 13% of pharmaceutical companies provide information about clinical trial opportunities or instructions on how to enroll in patient support programs.

Coordinated patient-centric care requires that everyone work from the same playbook. Investing in an integrated life sciences platform gives pharma companies an efficient, cost-effective solution that helps boost productivity, foster cross-team collaboration, and deliver personalized patient care at scale.

Addressing industry-specific needs and circumstances

Greater transparency and collaboration are especially important when it comes to clinical trials and advanced therapy management. Connecting trial teams, providers, patients, and clinical data on a compliant digital platform can power more successful trials by helping pharma companies bring greater — and more frequent — awareness of available therapies to providers. In turn, pharma companies benefit from easier patient recruitment and retention, and a more streamlined, complete view of the trial.

Developing and delivering cutting-edge cell and gene therapies requires an immense amount of cross-team collaboration. An integrated life sciences platform ensures the best possible outcomes by providing a secure way to automate therapy coordination, connect teams around the patient, and streamline the regenerative therapy lifecycle, at scale. This lets providers coordinate and schedule multiple appointments at the same time, ensure safety and compliance, and proactively identify bottlenecks so they can be addressed in real time.

Chapter 3: Connect the data dots 

Healthcare and life sciences organizations have a trove of data. What’s more, at least 53% of healthcare consumers are willing to provide even more data (including non-medical), provided they get better service in return. But having the data is not enough. Pharmaceutical companies need a way to organize big data to reap its benefits.

Data unification helps pharmaceutical organizations make the most of the information they already possess. Taking this step lets them synthesize data more easily and leverage that data much faster by overlaying automation and artificial intelligence (AI).

Automation and AI capabilities provide insights, analyses, and guidance on next steps. Pharmaceutical companies can use this information to understand whether certain actions or processes affect patient attrition; identify and proactively solve for barriers to care; and gain insight into what types of messaging and communication resonates most with both patients and providers. This type of information can also be used to boost productivity and operational efficiencies. Companies can track and analyze sales rep visits, service center operations, and even patient and provider responsiveness. They can then use what they learn to refine things like sales pitches, call center scripts, tutorials, and training.

The path to success is a connected one

Successfully navigating the constant changes in the industry requires that pharmaceutical companies find a way to balance both patient expectations and business goals. Unifying data is the key. Whether by increased adherence, easier access to personalized medicine, or speedier clinical trials, an integrated life sciences platform makes it possible to power business success through a series of connections, actions, and exchanges that enrich experiences and drive greater operational efficiency.